Artivion Inc. (AORT) exhibits 64.4% gross margins and 4.5% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 19.3x enterprise multiple and 4.8% implied options volatility.
Sustained 64.4% gross profitability converts into 7.6% operating margin and 4.5% ROIC, outpacing sector cost of capital.
ROIC: 4.5% // GM: 64.4%YoY revenue trajectory of +13.6% paired with 0.07% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +13.6% // FCF YLD: 0.07%Altman Z-Score of 2.46 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 2.46 // F-SCORE: 9/9Trading at 117.0x trailing P/E (98.3x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 117.0x // EV/EBITDA: 19.3xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $22.58 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 2.2% net margins.
NET MARGIN: 2.2% // D/E: 0.48x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for AORT & activate live FRED threshold breach alerts.